Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 EUR | +24.26% | +14.20% | +76.19% |
05:34pm | Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment | MT |
14/05 | Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- DRRX Stock
- DC8A Stock
- Charts DURECT Corporation